What You Should Know: - Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78% and caps out-of-pocket Lantus costs at $35 for all patients with commercial insurance. The price cut goes into effect January 1, 2024. - The price cut milestone comes in addition to decisions taken in June 2022 to lower diabetes medicines costs: the launch of an unbranded Lantus biologic at -60% versus Lantus list price, and a cap on out-of-pocket costs on insulin to $35 for all people
Read More
Diabetes| Type 1 & 2 Diabetes Management | Policy, News, Analysis, Insights - HIT Consultant
Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B
What You Should Know: - Sanofi has agreed to acquire Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), for $25.00 per share in cash, representing an equity value of approximately $2.9B. - The acquisition is a strategic fit for Sanofi at the intersection of the company’s growth in immune-mediated diseases and disease-modifying therapies in areas of high unmet
Read More
Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients
Today, food insecurity affects more than 41 million Americans and is prevalent among children and the elderly population. Food insecurity is defined as the limited availability of nutritionally adequate and safe food or the inability to acquire these foods in socially acceptable ways. As a result, food insecurity can exacerbate medical conditions driving up hospital/health systems patient care costs. To learn more about how healthcare providers can address food insecurity, we sat down with Dr.
Read More
Risky Business of Health Trackers: What Digital Health Leaders Need to Know
Gone are the days when healthcare information was only available to us at the doctor’s office or through the office's online portals, and that’s in part due to the rapidly growing popularity of wearable technology devices. It’s estimated that 1 in 5 adults in the U.S. use a fitness or health tracker to monitor things such as heart rate, blood pressure, sleep cycle, and stress. But this information is being used beyond just monitoring specific conditions. Take me, for example; I personally use my
Read More
Ryse Health Secures $6.5M for Type 2 Diabetes Care
What You Should Know: - Ryse Health, a healthcare technology company that’s committed to pursuing a world free from chronic diseases and raising the bar on Type 2 Diabetes care raises $6.5M in Series A funding led by Route 66 Ventures. The round also included support from W Health and Healthworx, the innovation and investment arm of CareFirst BlueCross BlueShield. - The company plans to use the funding to enable Ryse to continue to grow its team, strengthen its business operations, partner
Read More
Mayo’s Lucem Health Launches AI-Driven Early Disease Detection Platform
What You Should Know: - Lucem Health™ today announced the availability of its new early AI-driven disease detection solutions, Lucem Health Reveal that leverages existing EHR data to identify patients who may be at a higher risk of serious or chronic disease. - Reveal solutions surface previously undiscovered insights in readily available clinical data that can help provider organizations deliver greater clinical value for patients and more financial value to the organization. Early
Read More
Walmart & CareSource Partner to Address Racial Health Inequities
What You Should Know: - Today, Walmart announced a three-year agreement with the nonprofit organization, CareSource to address cardiometabolic conditions and maternal health in under-resourced and underserved communities. - The partnership expands the work Walmart and CareSource are doing to help improve care around maternal and child health in Georgia - the two launched a pilot in Georgia earlier this year to help Black maternal health across the state. Address
Read More
BrightInsight Adds ixlayer to BrightInsight Ecosystem to Improve Therapy Matching
What You Should Know: - BrightInsight announced that ixlayer has joined the BrightInsight Ecosystem, a network of more than 20 of the world’s leading healthcare and technology companies driving growth and adoption of digital health solutions. - The BrightInsight Ecosystem of partners collaborates to solve healthcare’s biggest challenges to drive digital innovation, adoption and engagement. Why It Matters Conditions such as high cholesterol, autoimmune
Read More
Ascensia Diabetes Care Partners with SNAQ to Support Mealtime Decision-Making
What You Should Know: - Ascensia Diabetes Care, a global diabetes care company announces a landmark global collaboration with SNAQ, an award-winning app-based solution that offers key insights on food and nutrition for people with diabetes (PWDs). - As part of the strategic collaboration, Ascensia and SNAQ will integrate their solutions to empower more PWDs to make impactful mealtime decisions, with a goal to improve diabetes management. Support Mealtime Decision-Making
Read More
Vida Health Expands its Cardiometabolic Capabilities
What You Should Know: - Vida Health is expanding its solution for chronic conditions by adding the ability to prescribe and deprescribe glucagon-like peptide 1 (GLP-1) agonists for both type 2 diabetes and obesity for appropriate patients. As part of Vida’s value-oriented treatments for cardiometabolic conditions, patients with obesity and diabetes will now be candidates for GLP-1 therapy within the Vida platform. - With the addition of GLP-1s and other obesity medications in higher acuity
Read More
